Alexandros-Georgios Chalamandaris

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated <i>MGMT</i> promoter: An international randomized phase III trial

Antonio Omuro, Alba A. Brandes, Ahmed Idbaïh et al. · Neuro-Oncology · 2022 · 485 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Robert R. Henry, Julio Rosenstock, Steven V. Edelman et al. · Diabetes Care · 2014 · 237 citations

Medicine, Pharmacology, Pharmacotherapy +15

Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin

Sunder Mudaliar, Robert R. Henry, Guenther Boden et al. · Diabetes Technology & Therapeutics · 2013 · 106 citations

Medicine, Endocrinology, Pharmacology +17

Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143

Antonio Omuro, David A. Reardon, John H. Sampson et al. · Neuro-Oncology Advances · 2022 · 69 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Common Genetic Polymorphisms and Haplotypes of Fibrinogen Alpha, Beta, and Gamma Chains Affect Fibrinogen Levels and the Response to Proinflammatory Stimulation in Myocardial Infarction Survivors

Bénédicte Jacquemin, Charalambos Antoniades, Fredrik Nyberg et al. · Journal of the American College of Cardiology · 2008 · 57 citations

Medicine, Cardiology, Genetics +13